Publications

Therapeutic Areas

Centers of Excellence

Sort by

Considerations for the utility of real-world evidence beyond trial data in advanced NSCLC: the case of frontline tyrosine kinase inhibitors

Authors: P Gaitonde, V Chirikov, S Kelkar, B Liljas

Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review

Authors: P Jain, L Badgujar, J Spoorendonk & K Buesch

Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe

Authors: MJ Bishton, G Salles, C Golfier, W Knauf, M Bocchia, D Turner, B Slama, J Harchowal, S Marshall, A Bosi, JJ Lleonart

Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)

Authors: R J Aspinall, M Hudson, S D Ryder, P Richardson, E Farrington, M Wright, R T Przemioslo, F Perez, M Kent, R Henrar, J Hickey, D L Shawcross

Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences

Authors: P A Powell, M Karimi, D Rowen, N Devlin, B van Hout, J E Brazier

Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer's disease

Authors: R B Lipton, L Podger, W F Stewart, D Gomez-Ulloa, W I Rodriguez, M C Runken, F B Barnes, D Serrano

The long-term healthcare utilization and economic burden of RSV infection in children ≤5 years in Japan: propensity score matched cohort study

Authors: V Chirikov, M Botteman, E A F Simões

A policy review of the introduction of the MenACWY vaccine in toddlers across multiple countries

Authors: C Valmas, E Arcà, M Hensen & H Rashid

Human Papillomavirus Vaccine impact and effectiveness in six high-risk populations: a systematic literature review

Authors: E Goodman, M Reuschenbach, A Kaminski, S Ronnebaum

Impact of hypomethylating agent use on hospital and emergency room visits, and predictors of early discontinuation in patients with higher-risk myelodysplastic syndromes

Authors: A M Zeidan, N Joshi, H Kale, W-J Wang, S Corman, T Salimi, R S Epstein

View older